Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acute encephalitis complicating acute polyradiculoneuritis].

S Attarian1, A Trebuchon, J Ph Azulay

  • 1Service de Neurologie et des maladies Neuromusculaires, CHU de La Timone, Marseille, France. sattarian@ap-hm.fr

Revue Neurologique
|May 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Neuromuscular MRI in CIDP Patients: Interest of a Multiparametric Approach.

European journal of neurology·2026
Same author

Current management and treatment of patients with myasthenia gravis in France: A survey of the neurologist's perspective.

Revue neurologique·2026
Same author

Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study.

Muscle & nerve·2026
Same author

The safety of COVID-19 vaccines in a large French series of patients with neuromuscular conditions and the impacts of vaccination on their daily lives.

Revue neurologique·2025
Same author

New treatment strategies in Myasthenia gravis.

Revue neurologique·2024
Same author

Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019).

Revue neurologique·2024
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Acute encephalopathy following intravenous immunoglobulin (IVIg) therapy for Guillain-Barré syndrome is a rare but serious side effect. Steroid treatment effectively resolved symptoms in this case, highlighting the need for vigilance.

Area of Science:

  • Neurology
  • Immunology

Background:

  • Acute Inflammatory Demyelinating Polyneuropathy (AIDP) is an autoimmune disorder affecting peripheral nerves.
  • Intravenous immunoglobulin (IVIg) is a common treatment for AIDP.

Observation:

  • A 43-year-old male developed acute encephalopathy with posterior leukoencephalopathy after IVIg for AIDP.
  • Cerebrospinal fluid showed marked pleocytosis prior to IVIg administration.

Findings:

  • Encephalopathy symptoms resolved completely with corticosteroid treatment.
  • This case presents unique cerebrospinal fluid findings compared to previously reported IVIg-associated encephalopathy.

Implications:

  • The encephalopathy may be a post-infectious meningo-encephalitis complicating AIDP or a rare IVIg side effect.

Related Experiment Videos

  • This potential adverse event associated with IVIg therapy warrants careful consideration and monitoring.